✦ LIBER ✦

Jaundice at Presentation Heralds Advanced Disease and Poor Prognosis in Patients with Ampullary Carcinoma

✍ Scribed by Naoyuki Yokoyama; Yoshio Shirai; Toshifumi Wakai; Shigenori Nagakura; Kohei Akazawa; Katsuyoshi Hatakeyama

Book ID: 105978845
Publisher: Springer
Year: 2005
Tongue: English
Weight: 87 KB
Volume: 29
Category: Article
ISSN: 0364-2313
DOI: 10.1007/s00268-004-7709-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ampullary carcinoma in patients under 50

Ampullary carcinoma in patients under 50 years of age with a poor prognosis

✍ Koji Yamaguchi; Munetomo Enjoji 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 English ⚖ 489 KB

Serum vascular endothelial growth factor

Serum vascular endothelial growth factor levels in pancreatic cancer patients correlate with advanced and metastatic disease and poor prognosis

✍ Anastasios J. Karayiannakis; Helen Bolanaki; Konstantinos N. Syrigos; Byron Asim 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Increased activity of nm23-H1 gene in sq

Increased activity of nm23-H1 gene in squamous cell carcinoma of the head and neck is associated with advanced disease and poor prognosis

✍ K. Pavelić; S. Kapitanović; S. Radošević; M. Bura; S. Seiwerth; L.J. Pavelić; J. 📂 Article 📅 2000 🏛 Springer 🌐 English ⚖ 288 KB

Phase II evaluation of cisplatin and eto

Phase II evaluation of cisplatin and etoposide followed by mitotane at disease progression in patients with locally advanced or metastatic adrenocortical carcinoma : A Southwest Oncology Group study

✍ Stephen K. Williamson; Danika Lew; Gary J. Miller; Stanley P. Balcerzak; Laurenc 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 2 views

## Background: A previous southwest oncology group study demonstrated a 30% response rate with the combination of cisplatin and mitotane in the treatment of patients with metastatic adrenocortical carcinoma. several case reports suggested that the combination of etoposide and cisplatin may be an ac

Three independently deleted regions at c

Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1–q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient

✍ Elo, J P; Härkönen, P; Kyllönen, A P; Lukkarinen, O; Vihko, P 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 107 KB